Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bauer

Showing results (871-880 of 985) with videos related to

Pageof 99
Sort By:
Pharmacopsychiatry|July 28, 2023
Lithium Therapy in Old Age: Recommendations from a Delphi SurveyJulia Christl, Bruno Müller-Oerlinghausen, Michael Bauer, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
Nature Immunology|January 5, 2021
Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarminAshley J Russo, Swathy O Vasudevan, Santiago P Méndez-Huergo, et al.
Frontiers in Immunology|March 26, 2021
Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic ShockRainer König, Amol Kolte, Olaf Ahlers, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studiesIlja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Schizophrenia Research|May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depressionRebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
Shock (Augusta, Ga.)|September 25, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2)Evangelos J Giamarellos-Bourboulis, Daniel Thomas-Rüddel, Aikaterini Pistiki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
International Journal of Bipolar Disorders|May 9, 2017
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parametersLeonardo Tondo, Maria Abramowicz, Martin Alda, et al.
Journal of Affective Disorders|February 18, 2026
Contribution of depressive symptom load on prediction of transition to bipolar disorders: Results from the prospective-longitudinal multi-method Early-BipoLife studyThore Petersen, Julia Martini, Michael Bauer, et al.
Pageof 99

Showing results (871-880 of 985) with videos related to

Sort By:
Pageof 99
Pharmacopsychiatry|July 28, 2023
Lithium Therapy in Old Age: Recommendations from a Delphi SurveyJulia Christl, Bruno Müller-Oerlinghausen, Michael Bauer, et al.
Intensive Care Medicine|October 4, 2021
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre-François Laterre, Peter Pickkers, Gernot Marx, et al.
Nature Immunology|January 5, 2021
Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarminAshley J Russo, Swathy O Vasudevan, Santiago P Méndez-Huergo, et al.
Frontiers in Immunology|March 26, 2021
Use of IFNγ/IL10 Ratio for Stratification of Hydrocortisone Therapy in Patients With Septic ShockRainer König, Amol Kolte, Olaf Ahlers, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 28, 2016
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studiesIlja Spellmann, Rebecca Schennach, Florian Seemüller, et al.
Schizophrenia Research|May 30, 2019
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depressionRebecca Schennach, Michael Obermeier, Ilja Spellmann, et al.
Shock (Augusta, Ga.)|September 25, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2)Evangelos J Giamarellos-Bourboulis, Daniel Thomas-Rüddel, Aikaterini Pistiki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple MyelomaEileen M Boyle, Patrick Blaney, James H Stoeckle, et al.
International Journal of Bipolar Disorders|May 9, 2017
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parametersLeonardo Tondo, Maria Abramowicz, Martin Alda, et al.
Journal of Affective Disorders|February 18, 2026
Contribution of depressive symptom load on prediction of transition to bipolar disorders: Results from the prospective-longitudinal multi-method Early-BipoLife studyThore Petersen, Julia Martini, Michael Bauer, et al.
Pageof 99